| 纳武利尤单抗联合伊匹木单抗一线治疗非小细胞肺癌的疗效 |
| |
| 引用本文： | 董晓荣,王千毓.纳武利尤单抗联合伊匹木单抗一线治疗非小细胞肺癌的疗效[J].循证医学,2020,20(1):43-48. |
| |
| 作者姓名： | 董晓荣 王千毓 |
| |
| 作者单位： | 1. 华中科技大学同济医学院附属协和医院肿瘤中心胸部肿瘤科, 武汉 430022;
2. 广东省人民医院肿瘤中心、广东省医学科学院、广东省肺癌研究所, 广州510080 |
| |
| 摘 要： |
|
| 关 键 词： | 非小细胞肺癌 Nivolumab Ipilimumab |
Efficacy of Nivolumab plus Ipilimumab as First-Line Treatment in Non-Small-Cell Lung Cancer |
| |
| DONG Xiao-rong,WANG Qian-yu.Efficacy of Nivolumab plus Ipilimumab as First-Line Treatment in Non-Small-Cell Lung Cancer[J].The Journal of Evidence-Based Medicine,2020,20(1):43-48. |
| |
| Authors: | DONG Xiao-rong WANG Qian-yu |
| |
| Institution: | Reviewer’s address：Department of Thoracic Oncology, Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology,Wuhan 430022, China |
| |
| Abstract: | |
| |
| Keywords: | non-small-cell lung cancer Nivolumab Ipilimumab |
|
| 点击此处可从《循证医学》浏览原始摘要信息 |
| 点击此处可从《循证医学》下载免费的PDF全文 |
